SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-126529
Filing Date
2020-04-29
Accepted
2020-04-29 17:15:17
Documents
13
Period of Report
2020-06-17
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d878734ddef14a.htm DEF 14A 840399
2 GRAPHIC g878734g16t43.jpg GRAPHIC 170151
3 GRAPHIC g878734g41p15.jpg GRAPHIC 20836
4 GRAPHIC g878734g44q12.jpg GRAPHIC 29033
5 GRAPHIC g878734g63s72.jpg GRAPHIC 55233
6 GRAPHIC g878734g75q32.jpg GRAPHIC 30379
7 GRAPHIC g878734g97q10.jpg GRAPHIC 62768
8 GRAPHIC g878734mm.jpg GRAPHIC 8849
9 GRAPHIC g878734pc01a.jpg GRAPHIC 8827
10 GRAPHIC g878734pc01b.jpg GRAPHIC 1939
11 GRAPHIC g878734pc01c.jpg GRAPHIC 1985
12 GRAPHIC g878734pc01d.jpg GRAPHIC 1898
13 GRAPHIC g878734pc02.jpg GRAPHIC 8947
  Complete submission text file 0001193125-20-126529.txt   1371546
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33277 | Film No.: 20831680
SIC: 2834 Pharmaceutical Preparations